Yokukansan (TJ-54) for treatment of very-late-onset schizophrenia-like psychosis: An open-label study

Phytomedicine

Volumn 20, Issue 7, 2013, Pages 654-658

  Miyaoka, Tsuyoshi ^a   Wake, Rei ^a   Furuya, Motohide ^a   Liaury, Kristian ^a   Ieda, Masa ^a   Kawakami, Kazunori ^a   Tsuchie, Keiko ^a   Fukushima, Michiyo ^a   Ishihara, Kotomi ^a   Araki, Tomoko ^a   Hashioka, Sadayuki ^a   Horiguchi, Jun ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Psychosis in the elderly; TJ 54; Treatment; Very late onset schizophrenia like psychosis

Indexed keywords

HERBACEOUS AGENT; TJ 24; UNCLASSIFIED DRUG; YOKUKANSAN;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; AGED; ARTICLE; BARNES AKATHISIA SCALE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; DSM-IV-TR; FEMALE; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SIMPSON-ANGUS SCALE; SYMPTOMATOLOGY;

AGE OF ONSET; AGED; ANTIPSYCHOTIC AGENTS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; JAPAN; MALE; PLANT PREPARATIONS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 84876415118     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.01.007     Document Type: Article

References (40)

1. G.S. Alexopoulos, J. Streim, D. Carpenter, and J.P. Docherty The expert consensus guideline series using antipsychotic agents in older patients Journal of Clinical Psychiatry 65 Suppl. 2 2004 4 99
2. R. Aizawa, T. Kanbayashi, Y. Saito, Y. Ogawa, T. Sugiyama, T. Kitajima, Y. Kaneko, M. Abe, and T. Shimizu Effects of yoku-kan-san-ka-chimpi-hange on the sleep of normal healthy adult subjects Psychiatry and Clinical Neurosciences 56 2002 303 304
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th edn. 2000 APA Washington, DC (text revision)
4. T.R.E. Barnes A rating scale for drug-induced akathisia British Journal of Psychiatry 154 1989 672 676
5. N. Egashira, K. Iwasaki, A. Ishibashi, K. Hayakawa, R. Okuno, M. Abe, N. Uchida, K. Mishima, K. Takasaki, R. Nishimura, R. Oishi, and M. Fujiwara Repeated administration of yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-HT2A receptors in the prefrontal cortex Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 2008 1516 1520
6. A. Essali, and G. Ali Antipsychotic drug treatment for elderly people with late-onset schizophrenia Cochrane Database of Systematic Reviews 15 2012 CD004162
7. D.P. Folsom, B.D. Lebowitz, and L.A. Lindamer Schizophrenia in late life: emerging issues Dialogues in Clinical Neuroscience 8 2006 45 52
8. M.F. Folstein, FolsteinSE, and P.R. McHugh 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 12 1975 189 198
9. Y. Hayashi, Y. Ishida, T. Inoue, M. Udagawa, K. Takeuchi, H. Yoshida, K. Kiue, Y. Ninomiya, J. Kawano, T. Sameshima, T. Kawahara, I. Goto, K. Shudo, S. Kurayama, J. Nakamura, K. Okahara, and Y. Mitsuyama Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with yokukansan in clinical practice Progress in Neuro-Psychopharmacology and Biological Psychiatry 16 2010 541 545
10. R. Howard, P.V. Rabins, M.V. Seeman, and D.V. Jeste The international late-onset Schizophrenia group late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus American Journal of Psychiatry 157 2000 172 178
11. Y. Ikarashi, S. Iizuka, S. Imamura, T. Yamaguchi, K. Sekiguchi, Z. Kawakami, M. Yuzurihara, Y. Kase, and S. Takeda Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats Biological and Pharmaceutical Bulletin 32 2009 170101709
12. K. Iwasaki, T. Satoh-Nakagawa, M. Maruyama, Y. Monma, M. Nemoto, H. Tanji, H. Fujiwara, T. Seki, M. Fujii, H. Arai, and H. Sasaki A randomized observer-blind, controlled trial of the traditional Chinese medicine Yi-gan san for improvement of behavioral and psychological symptoms and activities of daily living dementia patients Journal of Clinical Psychiatry 66 2005 248 252
13. K. Iwasaki, K. Kosaka, H. Mori, R. Okitsu, K. Furukawa, Y. Manabe, M. Yoshida, A. Kanamori, N. Ito, K. Wada, M. Kitayama, J. Horiguchi, S. Yamaguchi, R. Fukuhara, S. Oumura, S. Nakano, M. Hashimoto, and T. Kinoshita Open label trial to evaluate the efficacy and safety of yokukansan, a traditional Asian medicine, in dementia with Lewy bodies Journal of the American Geriatrics Society 59 2011 936 938
14. D.V. Jeste, D.G. Blazer, and M. First Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients Biological Psychiatry 58 2005 265 271
15. D.V. Jeste, C.R. Dolder, G.V. Nayak, and C. Salzman Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature Harvard Review of Psychiatry 13 2005 340 351
16. H. Jin, D. Folsom, A. Sasaki, S. Mudaliar, R. Henry, M. Torres, S. Golshan, D.K. Gloriso, and D. Jeste Increased Framingham 10-year risk of coronary heart disease in middle-age and older patients with psychotic symptoms Schizophrenia Research 125 2011 295 299
17. C.L.E. Katona Psychotropics and drug interactions in the elderly patient International Journal of Geriatric Psychiatry 16 2001 S86 S90
18. K. Kajitani, and S. Kanba Successful treatment of poststroke emotional incontinence with yokukansan, an Asian herbal medicine: report of two cases Journal of the American Geriatrics Society 60 2012 379 381
19. Z. Kawakami, H. Kanno, K. Ueki Terawaki, M. Tabuchi, Y. Ikarashi, and Y. Kase Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells Neuroscience 159 2009 1397 1407
20. T. Kawanabe, A. Yorita, H. Shimura, H. Oizumi, S. Tanaka, and N. Hattori Successful treatment with yokukansan for behavioral and psychological symptoms of parkinsonian dementia Progress in Neuro-Psychopharmacology and Biological Psychiatry 17 2010 284 287
21. S.R. Kay, A. Fiszbein, and L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophrenia Bulletin 13 1987 261 276
22. T. Kimura, H. Hayashida, H. Furukawa, and J. Takamatsu Pilot study of pharmacological treatment for frontotemporal dementia: effect of yokukansan on behavioral symptoms Psychiatry and Clinical Neurosciences 64 2010 207 210
23. F.F. Liao, Y.M. Jan, and S.Y. Huang Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs Proceedings of the National Science Council, Republic of China 19B 1995 151 158
24. T. Miyaoka, M. Furuya, H. Yasuda, M. Hayashida, T. Inagaki, and J. Horiguchi Yi-gan san for treatment of borderline personality disorder: an open-label study Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 2008 150 154
25. T. Miyaoka, M. Furuya, H. Yasuda, M. Hayashida, T. Inagaki, and J. Horiguchi Yi-gan san for treatment of neuroleptic-induced tardive dyskinesia: an open-label study Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 2008 761 764
26. T. Miyaoka, M. Furuya, H. Yasuda, M. Hayashida, T. Inagaki, and J. Horiguchi Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study Clinical Neuropharmacology 32 2009 6 9
27. T. Miyaoka, and J. Horiguchi Clinical potential of Yi-gan san (yokukansan) for psychiatric disorders Current Psychiatry Reviews 5 2009 271 275
28. T. Miyaoka, M. Nagahama, K. Tsuchie, M. Hayashida, A. Nishida, T. Inagaki, and J. Horiguchi Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with Yi-gan san Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 2009 382 383
29. T. Miyaoka, M. Furuya, L. Kristian, R. Wake, K. Kawakami, M. Nagahama, K. Kawano, M. Ieda, K. Tsychie, and J. Horiguchi Yi-gan san for treatment of Charles Bonnet syndrome (visual hallucination due to vision loss): an open-label study Clinical Neuropharmacology 34 2011 24 27
30. K. Mizukami, T. Asada, T. Kinoshita, K. Tanaka, K. Sonohara, R. Nakai, K. Yamaguchi, H. Hanyu, K. Kanaya, T. Takao, M. Okada, S. Kudo, H. Kotoku, M. Iwakiri, H. Kurita, T. Miyamura, Y. Kawasaki, K. Omori, K. Shinozaki, T. Odawara, T. Suzuki, S. Yamada, Y. Nakamura, and K. Toba A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioral and psychological symptoms of dementia International Journal of Neuropsychopharmacology 12 2009 191 199
31. A. Monji, M. Takita, T. Samejima, T. Takaishi, K. Hashimoto, H. Matsunaga, M. Oda, Y. Sumida, Y. Mizoguchi, and T. Kato Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 2009 308 311
32. K. Nakata, E. Yokoyama, T. Yamazaki, O. Takano, T. Maeda, S. Takashi, and Y. Terayama Effect of yokukansan on behavioral and psychological symptoms of vascular dementia; an open-label trial Phytomedicine 19 2012 524 528
33. National Institute of Mental Health CGI, Clinical Global Impression W. Guy, ECDEU Assessment Manual for Psychopharmacology, revised 1976 U.S. Dept. of Health, Education, and Welfare Rockville, MD 217 222
34. National Institute of Mental Health CGI, Clinical Global Impression W. Guy, ECDEU Assessment Manual for Psychopharmacology, revised 1976 U.S. Dept. of Health, Education, and Welfare Rockville, MD 534 537
35. K. Okahara, Y. Ishida, Y. Hayashi, T. Inoue, K. Tsuruta, K. Takeuchi, H. Yoshimura, K. Kiue, Y. Ninomiya, J. Kawano, K. Yoshida, S. Noda, S. Tomita, M. Fujimoto, J. Hosomi, and Y. Mistuyama Effects of yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease Progress in Neuro-Psychopharmacology and Biological Psychiatry 16 2010 532 536
36. L.S. Schneider, P.N. Tariot, and K.S. Dagerman for the CATIE-AD Study Group Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease New England Journal of Medicine 355 2006 1525 1538
37. Y. Shimada, H. Goto, and T. Itoh Evaluationa of the prospective effects of alkaloids from the hooks and stems of Uncaria sinesis of glutamate-induced neuronal death in cultured cerebellar granule cells from rats Journal of Pharmacy and Pharmacology 51 1999 715 722
38. G. Simpson, and J.A. Angus A rating scale for extrapyramidal side effects Acta Psychiatrica Scandinavica 70 1979 11 19
39. H. Sumiyoshi, A. Mantani, S. Nishiyama, S. Fujiwaki, S. Ohta, Y. Mastuda, Y. Tomita, N. Tarumoto, and S. Yamawaki Yokukansan treatment in chronic renal failure patients with dementia receiving hemodialysis: an open label study American Journal of Geriatrics Society 19 2011 906 907
40. M.A. Ventura, M.F. Green, A. Shaner, and R.P. Liberman Training and quality assurance with the brief psychiatric rating scale: 'The drift buster' International Journal of Methods in Psychiatric Research 3 1993 221 244